FEATURES OF BIGUANIDES IN COMBINATION THERAPY OF HYPERTENSION WITH METABOLIC SYNDROME

Metabolic syndrome (MS) in recent years has attracted more and more attention of doctors around the world, which is associated with its wide distribution, reaching 25-30% in the adult population, and increasing with age [1, 2, 7].